Ma C - Search Results

1

Prostate-specific antigen test result interpretation when combined with risk factors for recommendation of biopsy: a survey of urologist's practice patterns.

Lawrentschuk N, Daljeet N, Ma C, Hersey K, Zlotta A, Fleshner N. Lawrentschuk N, et al. Among authors: ma c. Int Urol Nephrol. 2011 Mar;43(1):31-7. doi: 10.1007/s11255-010-9772-1. Epub 2010 Jun 12. Int Urol Nephrol. 2011. PMID: 20544283

2

Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.

Crook JM, Gomez-Iturriaga A, Wallace K, Ma C, Fung S, Alibhai S, Jewett M, Fleshner N. Crook JM, et al. Among authors: ma c. J Clin Oncol. 2011 Feb 1;29(4):362-8. doi: 10.1200/JCO.2010.31.7305. Epub 2010 Dec 13. J Clin Oncol. 2011. PMID: 21149658 Clinical Trial.

3

Comparison of epidural and intravenous patient controlled analgesia in patients undergoing radical cystectomy.

Toren P, Ladak S, Ma C, McCluskey S, Fleshner N. Toren P, et al. Among authors: ma c. Can J Urol. 2009 Aug;16(4):4716-20. Can J Urol. 2009. PMID: 19671221

4

The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy.

Piña AG, Crook JM, Kwan P, Borg J, Ma C. Piña AG, et al. Among authors: ma c. Brachytherapy. 2010 Jul-Sep;9(3):213-8. doi: 10.1016/j.brachy.2009.09.002. Epub 2009 Dec 22. Brachytherapy. 2010. PMID: 20022565

5

10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.

Crook J, Borg J, Evans A, Toi A, Saibishkumar EP, Fung S, Ma C. Crook J, et al. Among authors: ma c. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1323-9. doi: 10.1016/j.ijrobp.2010.04.038. Epub 2010 Aug 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675072

6

Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy.

Gómez-Iturriaga Piña A, Crook J, Borg J, Ma C. Gómez-Iturriaga Piña A, et al. Among authors: ma c. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):422-7. doi: 10.1016/j.ijrobp.2009.07.1723. Int J Radiat Oncol Biol Phys. 2010. PMID: 20832665

7

Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.

Sturgeon JF, Moore MJ, Kakiashvili DM, Duran I, Anson-Cartwright LC, Berthold DR, Warde PR, Gospodarowicz MK, Alison RE, Liu J, Ma C, Pond GR, Jewett MA. Sturgeon JF, et al. Among authors: ma c. Eur Urol. 2011 Apr;59(4):556-62. doi: 10.1016/j.eururo.2010.12.010. Epub 2010 Dec 22. Eur Urol. 2011. PMID: 21190791

8

The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

Patil N, Crook J, Saibishkumar EP, Aneja M, Borg J, Pond G, Ma C. Patil N, et al. Among authors: ma c. Brachytherapy. 2009 Apr-Jun;8(2):218-222. doi: 10.1016/j.brachy.2008.12.001. Epub 2009 Feb 20. Brachytherapy. 2009. PMID: 19230790

9

Radiation therapy in the management of the primary penile tumor: an update.

Crook J, Ma C, Grimard L. Crook J, et al. Among authors: ma c. World J Urol. 2009 Apr;27(2):189-96. doi: 10.1007/s00345-008-0309-5. Epub 2008 Jul 18. World J Urol. 2009. PMID: 18636264

10

Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy.

Crook J, Patil N, Ma C, McLean M, Borg J. Crook J, et al. Among authors: ma c. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1079-84. doi: 10.1016/j.ijrobp.2009.06.040. Epub 2009 Oct 31. Int J Radiat Oncol Biol Phys. 2010. PMID: 19879700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,274 results

Search Page

Filters